{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:15:07Z","timestamp":1792790107356,"version":"4.5.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Forkhead box class O1 (FOXO1) acts as a tumor suppressor in solid tumors. The oncogenic phosphoinositide-3-kinase (PI3K) pathway suppresses FOXO1 transcriptional activity by enforcing its nuclear exclusion upon AKT-mediated phosphorylation. We show here abundant nuclear expression of FOXO1 in Burkitt lymphoma (BL), a germinal center (GC) B-cell\u2013derived lymphoma whose pathogenesis is linked to PI3K activation. Recurrent FOXO1 mutations, which prevent AKT targeting and lock the transcription factor in the nucleus, are used by BL to circumvent mutual exclusivity between PI3K and FOXO1 activation. Using genome editing in human and mouse lymphomas in which MYC and PI3K cooperate synergistically in tumor development, we demonstrate proproliferative and antiapoptotic activity of FOXO1 in BL and identify its nuclear localization as an oncogenic event in GC B-cell\u2013derived lymphomagenesis.<\/jats:p>","DOI":"10.1182\/blood-2018-06-856203","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T21:12:08Z","timestamp":1539810728000},"page":"2670-2683","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells"],"prefix":"10.1182","volume":"132","author":[{"given":"Eleni","family":"Kabrani","sequence":"first","affiliation":[{"name":"Immune Regulation and Cancer, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Trung","family":"Chu","sequence":"first","affiliation":[{"name":"Immune Regulation and Cancer, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany;"},{"name":"Berlin Institute of Health, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Tasouri","sequence":"first","affiliation":[{"name":"Adaptive Immunity and Lymphoma, German Cancer Research Center\/National Center for Tumor Diseases Heidelberg (NCT), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sommermann","sequence":"first","affiliation":[{"name":"Immune Regulation and Cancer, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ba\u00dfler","sequence":"first","affiliation":[{"name":"Department for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-4197","authenticated-orcid":false,"given":"Thomas","family":"Ulas","sequence":"first","affiliation":[{"name":"Department for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"first","affiliation":[{"name":"Department of Hematology, University Hospital\/University of Zurich, Zurich, Switzerland;"},{"name":"Department of Molecular Therapy in Haematology and Oncology, German Cancer Research Center\/NCT, Heidelberg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology and Tumorimmunology, Charite Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim L.","family":"Schultze","sequence":"first","affiliation":[{"name":"Department for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Rajewsky","sequence":"first","affiliation":[{"name":"Immune Regulation and Cancer, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Sander","sequence":"first","affiliation":[{"name":"Immune Regulation and Cancer, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Alliance, Berlin-Buch, Germany;"},{"name":"Adaptive Immunity and Lymphoma, German Cancer Research Center\/National Center for Tumor Diseases Heidelberg (NCT), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2020071009001107000_B1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"issue":"6352","key":"2020071009001107000_B2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/354389a0","article-title":"Intraclonal generation of antibody mutants in germinal centres","volume":"354","author":"Jacob","year":"1991","journal-title":"Nature"},{"issue":"40","key":"2020071009001107000_B3","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"K\u00fcppers","year":"2001","journal-title":"Oncogene"},{"issue":"24","key":"2020071009001107000_B4","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"56","key":"2020071009001107000_B5","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1038\/sj.onc.1207261","article-title":"Myc pathways provoking cell suicide and cancer","volume":"22","author":"Nilsson","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"2020071009001107000_B6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"issue":"7418","key":"2020071009001107000_B7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"1","key":"2020071009001107000_B8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2020071009001107000_B9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020071009001107000_B10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-800267-4.00004-3","article-title":"Signaling circuits in early B-cell development","volume":"122","author":"Reth","year":"2014","journal-title":"Adv Immunol"},{"issue":"6","key":"2020071009001107000_B11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.immuni.2015.10.021","article-title":"PI3 kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones","volume":"43","author":"Sander","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"2020071009001107000_B12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.immuni.2015.10.015","article-title":"The FOXO1 transcription factor instructs the germinal center dark zone program","volume":"43","author":"Dominguez-Sola","year":"2015","journal-title":"Immunity"},{"issue":"29","key":"2020071009001107000_B13","doi-asserted-by":"crossref","first-page":"19349","DOI":"10.1074\/jbc.M109.002725","article-title":"14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4","volume":"284","author":"Silhan","year":"2009","journal-title":"J Biol Chem"},{"issue":"11","key":"2020071009001107000_B14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; regulation by AKT and 14-3-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2020071009001107000_B15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/msb.2012.74","article-title":"Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling","volume":"9","author":"Eijkelenboom","year":"2013","journal-title":"Mol Syst Biol"},{"issue":"3","key":"2020071009001107000_B16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ni.2210","article-title":"A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation","volume":"13","author":"Ochiai","year":"2012","journal-title":"Nat Immunol"},{"issue":"14","key":"2020071009001107000_B17","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1158\/0008-5472.CAN-06-0411","article-title":"FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer","volume":"66","author":"Dong","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"2020071009001107000_B18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2011.08951.x","article-title":"The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival","volume":"156","author":"Obrador-Hevia","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2020071009001107000_B19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2006.12.029","article-title":"FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis","volume":"128","author":"Paik","year":"2007","journal-title":"Cell"},{"issue":"6","key":"2020071009001107000_B20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ccr.2013.05.002","article-title":"SYK inhibition modulates distinct PI3K\/AKT-dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas","volume":"23","author":"Chen","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"2020071009001107000_B21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood-2015-06-654111","article-title":"FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas","volume":"127","author":"Szydlowski","year":"2016","journal-title":"Blood"},{"issue":"15","key":"2020071009001107000_B22","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","article-title":"FOXO1 is a tumor suppressor in classical Hodgkin lymphoma","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2020071009001107000_B23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","article-title":"AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias [published correction appears in Cell. 2011;147(1):247]","volume":"146","author":"Sykes","year":"2011","journal-title":"Cell"},{"issue":"26","key":"2020071009001107000_B24","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood-2017-10-813576","article-title":"Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"Wang","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020071009001107000_B25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2407-11-264","article-title":"Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"issue":"19","key":"2020071009001107000_B26","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/onc.2016.426","article-title":"FOXO3 is essential for CD44 expression in pancreatic cancer cells","volume":"36","author":"Kumazoe","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"2020071009001107000_B27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.leukres.2009.04.024","article-title":"High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics","volume":"33","author":"Santamar\u00eda","year":"2009","journal-title":"Leuk Res"},{"issue":"6","key":"2020071009001107000_B28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.2772","article-title":"\u03b2-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer","volume":"18","author":"Tenbaum","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"2020071009001107000_B29","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/ijc.30690","article-title":"Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis","volume":"140","author":"Qian","year":"2017","journal-title":"Int J Cancer"},{"issue":"9","key":"2020071009001107000_B30","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/0008-5472.CAN-17-2511","article-title":"FOXO transcription factors both suppress and support breast cancer progression","volume":"78","author":"Hornsveld","year":"2018","journal-title":"Cancer Res"},{"issue":"7360","key":"2020071009001107000_B31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"18","key":"2020071009001107000_B32","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","article-title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","volume":"121","author":"Trinh","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2020071009001107000_B33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"2020071009001107000_B34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1073\/pnas.1017729108","article-title":"14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1 [published corrections appear in Proc Natl Acad Sci USA. 2011;108(16):6689 and Proc Natl Acad Sci USA. 2013;110(39):15849]","volume":"108","author":"Su","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5666","key":"2020071009001107000_B35","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"issue":"5","key":"2020071009001107000_B36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.febslet.2008.02.010","article-title":"O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene","volume":"582","author":"Kuo","year":"2008","journal-title":"FEBS Lett"},{"issue":"8","key":"2020071009001107000_B37","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1128\/MCB.16.8.4117","article-title":"Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways","volume":"16","author":"Klippel","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2020071009001107000_B38","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1210\/en.2003-0481","article-title":"Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion","volume":"144","author":"Tsai","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"2020071009001107000_B39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.18632\/aging.100208","article-title":"Intracellular protein glycosylation modulates insulin mediated lifespan in C. elegans","volume":"2","author":"Rahman","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"2020071009001107000_B40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcancer.2017.11.017","article-title":"Re-evaluating the role of FOXOs in cancer","volume":"50","author":"Hornsveld","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2020071009001107000_B41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20161263","article-title":"The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help","volume":"214","author":"Inoue","year":"2017","journal-title":"J Exp Med"},{"issue":"20","key":"2020071009001107000_B42","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2014-07-590570","article-title":"FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma","volume":"124","author":"Vogel","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2020071009001107000_B43","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1101\/gad.453107","article-title":"FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf","volume":"21","author":"Bouchard","year":"2007","journal-title":"Genes Dev"},{"issue":"6046","key":"2020071009001107000_B44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"issue":"6","key":"2020071009001107000_B45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ni.1616","article-title":"SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway","volume":"9","author":"Herzog","year":"2008","journal-title":"Nat Immunol"},{"issue":"4","key":"2020071009001107000_B46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2012.12.014","article-title":"Redox-dependent control of FOXO\/DAF-16 by transportin-1","volume":"49","author":"Putker","year":"2013","journal-title":"Mol Cell"},{"issue":"24","key":"2020071009001107000_B47","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/sj.emboj.7600476","article-title":"FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK","volume":"23","author":"Essers","year":"2004","journal-title":"EMBO J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/25\/2670\/1746818\/blood856203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/25\/2670\/1746818\/blood856203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T13:01:07Z","timestamp":1594386067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/132\/25\/2670\/39591\/Nuclear-FOXO1-promotes-lymphomagenesis-in-germinal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":47,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,12,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-06-856203","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}